Small Scale AAV Feasibility Studies & QC Testing at Pharmaron

Pharmaron Small Scale AAV Feasibility and QC Testing overview highlighting key features, ideal requirements, and early-stage product assessment benefits.

Accelerate AAV Development with Rapid & Scalable Feasibility Studies

Pharmaron provides multi-serotype AAV feasibility studies that offer a cost-effective, small-scale approach to assess viral vector performance before committing to large-scale production. Using our scalable AAV platform, we enable early-stage process optimization, transgene evaluation, and QC testing to streamline gene therapy development. With a 6 – 8 week turnaround, our feasibility studies deliver critical process and analytical data, ensuring that your AAV vector manufacturing strategy is optimized for efficiency and regulatory success.

Key Benefits of Pharmaron’s AAV Feasibility Studies:

  • Multi-Serotype AAV Testing – Supports all AAV serotypes using HEK293 cell lines
  • Rapid 6-8 Week Study Timeline – Accelerate development without long lead times
  • Small Volume Analytics – Maximized assay sensitivity while conserving AAV batches
  • Comprehensive QC & Stability Testing – Analytical insights into purity, potency, and impurities
  • Scalable Platform for Clinical Supply – Seamless transition to large-scale AAV manufacturing

Not sure which AAV candidate or serotype to select? Our customizable feasibility studies allow side-by-side comparisons to aid decision-making.

Advanced Analytical Testing for Small-Scale AAV Studies

  • Capsid ELISA – Viral protein titer analysis
  • Droplet Digital PCR – Viral genome titer quantification
  • Mass Photometry & AUC – Empty:Full capsid ratio determination
  • Residual Host Cell Impurity Assays – Ensuring high purity of AAV vectors

Pharmaron extends these small-volume analytics to AAV QC release testing and stability studies, ensuring compliance with regulatory expectations for clinical and commercial programs.

Why Choose Pharmaron for AAV Feasibility & QC Testing?

  • Proven Expertise in AAV Vector Process Development
  • Advanced Analytics for Precision Data & Regulatory Compliance
  • Seamless Transition from Feasibility to Clinical-Scale AAV Manufacturing

Optimize your AAV vector manufacturing early. Download our service overview to explore our small-scale AAV solutions.

Download Our Service Overview